General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy
- PMID: 1001359
- DOI: 10.1007/BF00563080
General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy
Abstract
A constant plasma drug concentration can be achieved and maintained by the intravenous administration of an initial bolus loading dose in conjunction with a constant rate and an exponential intravenous drug infusion. The drug input required to achieve a constant plasma drug concentration is derived without making any assumptions about the nature of drug distribution within the body or elimination from the body.
Similar articles
-
A new method for constant plasma drug concentrations: application to lidocaine.Ann Intern Med. 1984 Jan;100(1):25-8. doi: 10.7326/0003-4819-100-1-25. Ann Intern Med. 1984. PMID: 6691655
-
Pharmacokinetic approach to the clinical use of lidocaine intravenously.JAMA. 1976 Jul 19;236(3):273-7. JAMA. 1976. PMID: 947029
-
General theory for rapidly establishing steady state drug concentrations using two consecutive constant rate intravenous infusions.Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):235-8. doi: 10.1007/BF00614023. Eur J Clin Pharmacol. 1975. PMID: 1233268
-
Is volume of distribution at steady state a meaningful kinetic variable?J Clin Pharmacol. 1983 Aug-Sep;23(8-9):391-400. doi: 10.1002/j.1552-4604.1983.tb02753.x. J Clin Pharmacol. 1983. PMID: 6355205 Review.
-
Lidocaine clinical pharmacokinetics.Drug Intell Clin Pharm. 1982 Apr;16(4):291-4. doi: 10.1177/106002808201600403. Drug Intell Clin Pharm. 1982. PMID: 7040025 Review.
Cited by
-
A computer-based system for controlling plasma opioid concentration according to patient need for analgesia.Clin Pharmacokinet. 1991 Apr;20(4):319-30. doi: 10.2165/00003088-199120040-00006. Clin Pharmacokinet. 1991. PMID: 2036749
-
Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.J Pharmacokinet Biopharm. 1979 Apr;7(2):207-25. doi: 10.1007/BF01059739. J Pharmacokinet Biopharm. 1979. PMID: 20218015 Review.
-
The disposition of intravenous doxapram in man.Eur J Clin Pharmacol. 1979;16(6):411-6. doi: 10.1007/BF00568202. Eur J Clin Pharmacol. 1979. PMID: 527638
-
Rapid attainment of steady state plasma drug concentrations within precise limits.J Pharmacokinet Biopharm. 1998 Jun;26(3):319-28. doi: 10.1023/a:1023285426388. J Pharmacokinet Biopharm. 1998. PMID: 10098102
-
A model-independent proof of Dost's law of corresponding areas.J Pharmacokinet Biopharm. 1977 Jun;5(3):271-6. doi: 10.1007/BF01065400. J Pharmacokinet Biopharm. 1977. PMID: 881645 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources